AMH and breast carcinoma: At baseline, AMH levels were highest in healthy controls (Dolinko et al., 2018: 3.4 ± 3.3 ng/ml) (27) and in breast cancer patients before chemotherapy (Silva et al., 2019: 3.07 ± 2.95 ng/ml) (22).